25.66
0.54 (2.15%)
Previous Close | 25.12 |
Open | 25.23 |
Volume | 443,095 |
Avg. Volume (3M) | 246,480 |
Market Cap | 1,040,092,160 |
Price / Earnings (TTM) | 32.90 |
Price / Sales | 0.880 |
Price / Book | 3.91 |
52 Weeks Range | |
Earnings Date | 26 Aug 2025 - 1 Sep 2025 |
TTM Dividend Yield | 1.40% |
Profit Margin | 2.67% |
Operating Margin (TTM) | 11.39% |
Diluted EPS (TTM) | 0.780 |
Quarterly Revenue Growth (YOY) | 32.10% |
Quarterly Earnings Growth (YOY) | 148.40% |
Total Debt/Equity (MRQ) | 289.49% |
Current Ratio (MRQ) | 2.91 |
Operating Cash Flow (TTM) | 87.28 M |
Levered Free Cash Flow (TTM) | -67.58 M |
Return on Assets (TTM) | 6.26% |
Return on Equity (TTM) | 11.86% |
Market Trend
Short Term | Medium Term | ||
Industry | Drug Manufacturers - Specialty & Generic (US) | Bearish | Mixed |
Drug Manufacturers - Specialty & Generic (Global) | Bearish | Mixed | |
Stock | Phibro Animal Health Corporatio | Bullish | Bullish |
AIStockmoo Score
Analyst Consensus | 1.5 |
Insider Activity | NA |
Price Volatility | -3.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 4.0 |
Average | 1.13 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries. |
|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Investment Style | Small Core |
% Held by Insiders | 0.59% |
% Held by Institutions | 105.26% |
52 Weeks Range | ||
Median | 26.00 (1.33%) | |
Total | 1 Hold |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Morgan Stanley | 25 Jun 2025 | 26.00 (1.33%) | Hold | 24.75 |
08 May 2025 | 21.00 (-18.16%) | Hold | 22.25 |
No data within this time range.
Date | Type | Details |
---|---|---|
22 May 2025 | Announcement | Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference |
07 May 2025 | Announcement | Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance |
06 May 2025 | Announcement | Phibro Animal Health Corporation Declares Quarterly Dividend |
23 Apr 2025 | Announcement | Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results |
TTM Dividend Yield | 1.40% |
5Y Average Dividend Yield | 2.97% |
Payout Ratio | 61.54% |
Expected Next Dividend Payment | Sep 2025 |
Ex Date | Announcement Date | Payment Date | Details |
---|---|---|---|
05 Mar 2025 | 04 Feb 2025 | 26 Mar 2025 | 0.12 Cash |
27 Nov 2024 | 05 Nov 2024 | 18 Dec 2024 | 0.12 Cash |
04 Sep 2024 | 30 Jul 2024 | 25 Sep 2024 | 0.12 Cash |
05 Jun 2024 | 07 May 2024 | 26 Jun 2024 | 0.12 Cash |
05 Mar 2024 | 06 Feb 2024 | 27 Mar 2024 | 0.12 Cash |
28 Nov 2023 | 06 Nov 2023 | 20 Dec 2023 | 0.12 Cash |
05 Sep 2023 | 25 Jul 2023 | 27 Sep 2023 | 0.12 Cash |
06 Jun 2023 | 01 May 2023 | 28 Jun 2023 | 0.12 Cash |
28 Feb 2023 | 06 Feb 2023 | 22 Mar 2023 | 0.12 Cash |
29 Nov 2022 | 07 Nov 2022 | 21 Dec 2022 | 0.12 Cash |
06 Sep 2022 | 25 Jul 2022 | 28 Sep 2022 | 0.12 Cash |
31 May 2022 | 02 May 2022 | 22 Jun 2022 | 0.12 Cash |
01 Mar 2022 | 07 Feb 2022 | 23 Mar 2022 | 0.12 Cash |
23 Nov 2021 | 01 Nov 2021 | 15 Dec 2021 | 0.12 Cash |
31 Aug 2021 | 26 Jul 2021 | 22 Sep 2021 | 0.12 Cash |
01 Jun 2021 | 03 May 2021 | 23 Jun 2021 | 0.12 Cash |
02 Mar 2021 | 01 Feb 2021 | 24 Mar 2021 | 0.12 Cash |
24 Nov 2020 | 02 Nov 2020 | 16 Dec 2020 | 0.12 Cash |
01 Sep 2020 | 27 Jul 2020 | 23 Sep 2020 | 0.12 Cash |
02 Jun 2020 | 04 May 2020 | 24 Jun 2020 | 0.12 Cash |
03 Mar 2020 | 03 Feb 2020 | 25 Mar 2020 | 0.12 Cash |
26 Nov 2019 | 04 Nov 2019 | 18 Dec 2019 | 0.12 Cash |
03 Sep 2019 | 29 Jul 2019 | 25 Sep 2019 | 0.12 Cash |
04 Jun 2019 | 06 May 2019 | 26 Jun 2019 | 0.12 Cash |
05 Mar 2019 | 06 Feb 2019 | 27 Mar 2019 | 0.12 Cash |
27 Nov 2018 | 05 Nov 2018 | 19 Dec 2018 | 0.12 Cash |
04 Sep 2018 | 30 Jul 2018 | 26 Sep 2018 | 0.1 Cash |
05 Jun 2018 | 07 May 2018 | 27 Jun 2018 | 0.1 Cash |
06 Mar 2018 | 05 Feb 2018 | 28 Mar 2018 | 0.1 Cash |
05 Dec 2017 | 06 Nov 2017 | 27 Dec 2017 | 0.1 Cash |
01 Sep 2017 | 24 Jul 2017 | 27 Sep 2017 | 0.1 Cash |
26 May 2017 | 08 May 2017 | 22 Jun 2017 | 0.1 Cash |
27 Feb 2017 | 06 Feb 2017 | 22 Mar 2017 | 0.1 Cash |
28 Nov 2016 | 07 Nov 2016 | 21 Dec 2016 | 0.1 Cash |
02 Sep 2016 | 25 Jul 2016 | 28 Sep 2016 | 0.1 Cash |
27 May 2016 | 09 May 2016 | 22 Jun 2016 | 0.1 Cash |
29 Feb 2016 | 08 Feb 2016 | 23 Mar 2016 | 0.1 Cash |
30 Nov 2015 | 09 Nov 2015 | 23 Dec 2015 | 0.1 Cash |
31 Aug 2015 | 27 Jul 2015 | 23 Sep 2015 | 0.1 Cash |
01 Jun 2015 | 11 May 2015 | 24 Jun 2015 | 0.1 Cash |
02 Mar 2015 | 09 Feb 2015 | 25 Mar 2015 | 0.1 Cash |
01 Dec 2014 | 10 Nov 2014 | 23 Dec 2014 | 0.1 Cash |
29 Aug 2014 | 28 Jul 2014 | 24 Sep 2014 | 0.1 Cash |
Show more |
Annual Dividend Yield
Year | Annual Dividend ($) | Frequency/Year | Yield % |
---|---|---|---|
2025 | 0.120 | 1 | 0.47 |
2024 | 0.480 | 4 | 2.29 |
2023 | 0.480 | 4 | 4.15 |
2022 | 0.480 | 4 | 3.58 |
2021 | 0.480 | 4 | 2.35 |
2020 | 0.480 | 4 | 2.47 |
2019 | 0.480 | 4 | 1.93 |
2018 | 0.420 | 4 | 1.31 |
2017 | 0.400 | 4 | 1.19 |
2016 | 0.400 | 4 | 1.37 |
2015 | 0.400 | 4 | 1.33 |
2014 | 0.200 | 2 | 0.63 |
Show more |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |